Ginkgo Bioworks Holdings, Inc. DNA
11.65 USD +0.89 (+8.27%)
At closeNov 4, 2026, 7:28 PM EST
11.49 -0.16 -1.37%
After hours · Nov 4, 7:28 PM ET
10.76 Day range 11.77
5.37 52-week range 18.22
- YTD
- +40.19%
- 1 year
- +0.52%
Financial health
Altman Z-Score
-8.67 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -1.5×
FY 2019 5y median -1.5× FY 2025
P/S 2.7×
FY 2019 5y median 5.9× FY 2025
P/B 0.9×
FY 2019 5y median 1.6× FY 2025
P/FCF -2.6×
FY 2019 5y median -9.3× FY 2025
EV/EBITDA -2.9×
FY 2019 5y median -2.9× FY 2025
EV/Sales 4.3×
FY 2019 5y median 4.3× FY 2025
FCF Yield -38.8%
FY 2019 5y median -10.7% FY 2025
Profitability
Gross Margin 81.5%
FY 2019 5y median 78.5% FY 2025
Operating Margin -185.3%
FY 2019 5y median -343.8% FY 2025
Net Margin -183.8%
FY 2019 5y median -355.1% FY 2025
ROE -61.5%
FY 2019 5y median -81.4% FY 2025
ROIC -30.0%
FY 2019 5y median -56.9% FY 2025
ROA -27.9%
FY 2019 5y median -53.6% FY 2025
Growth (YoY)
Revenue -25.1%
FY 2019 FY 2025
Operating Income 43.7%
FY 2019 FY 2025
EPS (diluted) 46.5%
FY 2019 FY 2025
Free Cash Flow 53.2%
FY 2019 FY 2025
Financial Health
Current Ratio 4.9×
FY 2019 5y median 6.1× FY 2025
Quick Ratio 4.9×
FY 2019 5y median 6.1× FY 2025
Debt / Equity 0.9×
FY 2019 5y median 0.3× FY 2025
Net Debt / EBITDA -1.1×
FY 2019 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2019 5y median -5955× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31